need help with your account or subscription? click here to email us (or see the contact page)
join telegramNEW! discord
jump to exam page:
search for anything ⋅ score predictor (โ€œpredict me!โ€)
NBME 17 Answers

nbme17/Block 4/Question#30 (reveal difficulty score)
A 45-year-old man comes to the physician ...
Tumor necrosis factor ๐Ÿ” / ๐Ÿ“บ / ๐ŸŒณ / ๐Ÿ“–
tags: pharm Immuno

 Login (or register) to see more

 +3  upvote downvote
submitted by โˆ—cassdawg(1779)

Monoclonal antibodies used for inflammatory bowel disease include infliximab and adalimumab, both of which are directed against TNFalpha (FA2020 p382, 122, 487)

Another way of thinking about this is to think about common therapeutic antibodies used as well as the function of the other things listed to eliminate them. TNFalpha is commonly blocked by biologics for therapy in autoimmune and inflammatory disease, and generally it makes sense it would be beneficial to block as it is one of the primary pro-inflammatory cytokines

Bradykinin is involved in inflammation but has no major therapeutic Abs targeting it. C5a is an anaphylotoxin, and though monoclonal antibodies targeting C5 do exist they are used to treat paroxysmal noturnal hemoglobinuria. C5a does not play a major role in the pathogenesis of IBD. Blocking class I MHC antigens does not make sense, as antigens are what elicit the immune response and are presented to T-cells and there are millions of possible antigens that could be presented that are eliciting the inflammatory response. If you block class I MHC ittself it would also be extremely detrimental as then CD8 T-cells would not be able to respond to any infection/etc. Fibrin is involved in the clotting pathway and would not be beneficial to block in IBD. PGE2 is associated with pain, but it is not targeted by any therapeutic antibodies.

 Login (or register) to see more
cheesetouch  FA P472 adalimumab/infliximab Anti-TNF-a monoclonal Ab +2
murad  thank you so much for providing the FA 2018 page number always +

Must-See Comments from nbme17

cassdawg on Membrane lipid peroxidation
cassdawg on Haemophilus influenzae type b
cassdawg on Pelvic Splanchnic
cassdawg on Actinic keratosis
cassdawg on Early septic shock
cassdawg on Epinephrine
waitingonprometric on Tubular adenoma
flapjacks on Placebo effect
cassdawg on 0.9% Saline
bingcentipede on Surface kappa:surface lambda ratio
cassdawg on Free T4
tinyhorse on 25%
cassdawg on Absence of functional LDL receptors in ...
bingcentipede on Residual volume: โ†‘; Arterial PO2: โ†“; ...

search for anything NEW!